Cambridge, United Kingdom – Congenica, the digital health company enabling rapid and accurate analysis of complex genomic data to transform people’s lives, is pleased to announce the appointment of Dr. Sam Roberts as Non-Executive Director to the Board. Sam is the Managing Director of Health & Care at Legal & General. Her appointment follows Congenica’s US$50m […]
BERKELEY, Calif — Correlia Biosystems, a Berkeley, CA based life science startup, announced today that it has closed a $7 million Series A financing round with select global investors. Neotribe Ventures led the investment round, joined by Cota Capital, the Regents of the University of California, and others. This funding enables commercial launch of Correlia’s […]
MOBILion Systems, Inc., a pioneer in fast, efficient, high-resolution instrumentation for biomarker discovery, diagnostics and therapeutic development, is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in specific brain regions that contribute to the early onset and progression of Parkinson’s disease. The assembled international team brings together the […]
SAN DIEGO, Calif. — Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced the pricing of its upsized initial public offering of 60,000,000 shares of Class A common stock at a public offering price of $27.00 per share, before underwriting discounts and […]
HAMBURG, Germany & CAMBRIDGE, Mas. — Ultivue and Indivumed Inc. today announced that the two companies have entered into a collaborative partnership to further accelerate research and drug development in the area of personalized oncology. The deal links Indivumed’s vast array of standardized and fully comparable tissue biospecimens and analytical experience in IHC technology with Ultivue’s InSituPlex platform […]
Photo by National Cancer Institute on Unsplash shows human colorectal cancer cells treated with an inhibitor under study as a cancer therapy. Created by Yves Pommier, Rozenn Josse. Griffith University will establish a Centre of Excellence (CoE) in spatial biology in collaboration with Nanostring Technologies, a publicly held provider of life science tools for translational research […]
Spatial Analysis of up to 30 Proteins on FFPE Tumor Biopsies May Inform Patient Treatment Decisions SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced a collaboration with Oregon Health & Science University (OHSU) for their development of novel GeoMx® Digital Spatial Profiler (DSP) […]
VANCOUVER, Wash.– AbSci, a growth-stage synthetic biology company whose Protein Printing™ technology enables rapid and low-cost biomanufacturing and discovery of biotherapeutics, today announced that Ivana Magovčević-Liebisch and Karen McGinnis have joined its board as independent directors. “We are delighted to welcome Ivana and Karen to our board of directors,” said Sean McClain, Founder and CEO […]
GeoMx Digital Spatial Profiler (DSP) Now Enables Multi-Analyte Spatial Analysis Using Both NGS and nCounter Read-outs SEATTLE — NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced the launch of GeoMx® DSP Protein Assays for next generation sequencing (NGS) readout, enabling multi-analyte analysis for both nCounter® […]
Company elects luminary as Chairman as they reimagine where Mass Spec technology can be used when it is small in size, low in cost, and simple to operate BOSTON — 908 Devices, a pioneer of purpose-built handheld and desktop Mass Spec devices for chemical and biomolecular analysis, today announced the appointment of Kevin Hrusovsky as the Chairman of […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
